Wyeth's albumin-free ReFacto AF approved in EU for haemophilia
This article was originally published in Scrip
Executive Summary
Wyeth has secured approval from the European Commission for its albumin-free ReFacto AF (moroctocog alfa) for patients with haemophilia A.